Meet the Teams

The Prostate Project funds The Prostate Project Foundation which gives financial support to the Oncology team in the Faculty of Health and Medical Sciences (FHMS) at the University of Surrey.

In fact the charity was pivotal in the creation of this group providing 50% of the start-up funding. The team has 24 members with an extensive range of experience, from laboratory-based projects involving basic cell and molecular biology to the delivery of clinical trials in human cancers. The group is supported by the infrastructure required to undertake complex, multi-disciplinary studies. A particular strength of the team, which other cancer research centres find difficult to access, is the acquisition of patient samples (after suitable ethical approval) and this is partly due to the strong links and close collaborative relationships between clinicians and scientists with the local Royal Surrey County Hospital, and the neighbouring St Luke’s Cancer Centre and the Surrey Clinical Research Centre (CRC).

The internationally acclaimed group is led by Professor Hardev Pandha who is also a Trustee of our charity. The group are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of cancer. The group has an established track record for the supervision of MD and PhD students and has published an impressive 110 original peer reviewed papers since arriving at Surrey. The group has an active portfolio of phase I, II and III trials in new cancer therapies (small molecule inhibitors, cancer vaccine, viral and gene therapy). To find out more about the Oncology research team at the FHSM, visit: http://www2.surrey.ac.uk/microbial/Research/cancer/index.htm

Much of our research team’s work requires expensive clinical and laboratory trials to gain peer recognition and NICE approval. You can help us achieve this. Every contribution made, no matter how small, is another step on the road to saving more of the 11,000 lives that are lost every year in the UK to prostate cancer.